Introduction
Infections caused by multi-resistant Staphylococcus aureus strains still remain a problem in many health care institutions. 1 Methicillinresistant S. aureus (MRSA) represents a major cause of nosocomial infections, and the emergence of strains with intermediate susceptibility and resistance to glycopeptides reinforces the potential for spread of resistance determinants among bacteria and emphasizes the need for alternative therapeutic options. 2 Macrolide, lincosamide and streptogramin B (MLS B ) antibiotics are chemically distinct, but have similar effects on bacterial protein synthesis. 3, 4 Treatment of staphylococcal infections using MLS B antibiotics is commonplace but it is often accompanied by increased numbers of resistant strains. 3, 4 The mechanisms responsible for resistance to erythromycin in staphylococci are target site modification and active drug efflux. 3, 4 Target site modification is mediated by the presence of erm genes [erm(A), erm(B) and erm(C)] conferring resistance to MLS B antibiotics. 3, 4 Phenotypic expression of MLS B resistance can be inducible or constitutive. 3, 4 On the other hand, macrolide efflux is effected by membrane proteins encoded by the msr(A)/msr(B) genes and is specific for the 14-and 15-membered macrolides and streptogramin B (MS phenotype); lincosamide and streptogramin A antibiotics remain unaffected. 3, 4 The purpose of this study was to investigate the prevalence of erythromycin resistance in S. aureus clinical isolates in Greece, to examine the genetic mechanisms of resistance and to analyse clonality by molecular methods.
Materials and methods

Bacterial isolates
The study included 1477 S. aureus clinical isolates collected during a 3 year period (1999) (2000) (2001) 
PCR
Primers were chosen for the antibiotic resistance genes mecA (sense: 5′-GGTCCCATTAACTCTGAAG-3′ and anti-sense: 5′-AGTTCTGCAG-TACCGGATTTGC-3′), 7 erm(A) (sense: 5′-GTTCAAGAACAAT-CAATACAGAG-3′ and anti-sense: 5′-GGATCAGGAAAAGGACAT TTTAC-3′), erm(B) (sense: 5′-CCGTTTACGAAATTGGAACAGGT AAAGGGC-3′ and anti-sense: 5′-GAATCGAGACTTGAGTGTGC-3′), erm(C) (sense: 5′-GCTAATATTGTTTAAATCGTCAATTCC-3′ and anti-sense: 5′-GGATCAGGAAAAGGACATTTTAC-3′), msr(A) (sense: 5′-GGCACAATAAGAGTGTTTAAAGG-3′ and anti-sense: 5′-AAGTTATATCATGAATAGATTGTCCTGTT-3′) and msr(B) (sense: 5′-TATGATATCCATAATAATTATCCAATC-3′ and antisense: 5′-AAGTTATATCATGAATAGATTGTCCTGTT-3′). 3 Total DNA was extracted from all isolates expressing resistance to macrolides-lincosamides and PCR was carried out. 3 The presence of mecA, erm(A), erm(B), erm(C) and msr(A)/msr(B) genes was identified by agarose gel electrophoresis of PCR products. Three erythromycin-susceptible S. aureus isolates were included as negative controls in all experiments. Streptococcus pyogenes O2C 1064 and S. pyogenes O2C 1061 were used as positive controls for the detection of erm(A) and erm(B) genes, respectively.
Plasmid extraction was carried out in all erm(C)-positive isolates (Qiagen midi plasmid purification kit; Qiagen, Valencia, CA, USA) and the presence of the gene was investigated by PCR.
Hybridization
Total DNA was extracted from the erythromycin-resistant S. aureus isolates into agarose discs as described previously. 1 The presence of the resistance genes was verified by hybridization of ClaI DNA digests with the specific mecA and erm(A) probes and the Tn554 transposon labelled by the chemiluminescence ECL kit (Amersham, Pharmacia Biotech, Buckinghamshire, UK). The mecA and erm(A)-specific DNA probes were prepared after amplification of chromosomal DNA of S. aureus BB270 (mecA-positive) and plasmid DNA from E. coli RN7951 carrying Tn554, using the aforementioned primers. PCR products were purified by the Wizard DNA purification system (Promega, Madison, WI, USA) and used as DNA probes.
Clonal types
Pulsed-field gel electrophoresis (PFGE) of SmaI DNA digests was carried out as described previously. 1 One to six band differences defined a PFGE subtype and seven or more band differences defined a distinct PFGE type. Clones of MRSA were defined by the combination of ClaImecA types ClaI-Tn554 polymorphisms and PFGE patterns, 1 after comparison with previously identified MRSA clones in Patras University Hospital and reference strains. 1
Results and discussion
Of the 1477 S. aureus isolates, 173 (11.7%) expressed resistance to erythromycin (Table 1 ). The constitutive phenotype was detected in 106 isolates (61.3%), the inducible phenotype in 53 (30.6%) and the MS phenotype in 13 isolates (7.5%). Sixty isolates were MSSA (14 from Patras and 46 from Thessalia) and 113 MRSA (73 from Patras and 40 from Thessalia) ( Table 1) . No isolate expressed resistance to quinupristin/dalfopristin (MICs ≤ 1 mg/L). 3 MSSA isolates expressed the inducible or the MS phenotypes (Table 2) . Isolates bearing the inducible MLS B phenotype possessed the erm(A) gene (58.3%) or the erm(C) gene (20%). The 13 isolates carrying the msr(A) gene expressed the MS phenotype (Table 2) . It is worth mentioning that we identified six MSSA with erythromycin MICs of 1-3 mg/L, expressing inducible resistance and harbouring the erm(A) or erm(C) genes (Table 2) . Martineau et al. 8 have also reported the identification of four S. aureus isolates susceptible by disc diffusion that carried the erm(C) gene conferring resistance to macrolides.
Among the MRSA, only six expressed inducible MLS B resistance, whereas the rest expressed the constitutive MLS B phenotype. 3, 4, 8 Most of the MRSA isolates carried the erm(C) gene (109 isolates, see Table 3 ), followed by erm(A) (three isolates), whereas in other studies, even though it was predominant in the total S. aureus population, erm(C) was common among MSSA as well as coagulasenegative staphylococci. 9,10 One isolate carried both erm(A) and erm(C) genes, a genotype that has been infrequently reported. 9 No msr(A)-positive MRSA was identified.
Most of the S. aureus isolates in our study carried the erm(C) gene (70%) followed by the erm(A) gene (22%) and the msr(A) gene (7.5%), and one isolate carried both the erm(A) and erm(C) genes (0.6%) (Tables 2 and 3 ). This finding is in agreement with the results from 15 German University Hospitals which identified predominance of the erm(C) gene among S. aureus, 10 whereas most (42) 60 (5) 173 (11.7) studies report erm(A) as the most frequent genetic determinant. 3, 8, 9 In this collection, no isolate was found to be positive for the erm(B) and msr(B) genes. 3,9 PFGE analysis classified the MSSA into eight types (Figure 1) . Seventeen of the 60 MSSA, including five isolates with erythromycin MICs of 1-3 mg/L, belonged to PFGE type A, a pulsotype already identified among MRSA strains of Patras University Hospital from 1993. 1 The remaining clonal types of MSSA were not related to previously identified clones (Table 2) . MRSA isolates expressing the inducible MLS B phenotype belonged to PFGE types A and C endemic in the same hospital (Figure 1 ). 1 Ninety-nine of 104 MRSA with the constitutive MLS B phenotype carrying the erm(C) gene belonged to two multi-resistant clones-III′::KK::B and X′::KK::B (Table 3) . 1 These clones were distributed among strains of both University Hospitals. MRSA isolates carrying the erm(A) gene belonged to different clones (one strain each).
The transfer of erm(A), which is a part of Tn554, was shown to occur via transposition and one should expect the dissemination of a limited number of clones among erm(A)-positive isolates. 6, 10 In our collection, it seems that erm(A)-positive S. aureus strains are distinct, since they belong to different clones. erm(C) is located in small plasmids that cannot be transferred by conjugation or mobilization by larger conjugative plasmids. 8, 10 Our results showed that the majority of erm(C)-positive MRSA isolates belonged to two clones even though they were isolated in two distinct hospitals. The prevalence of erm(C)-positive isolates is most likely due to the selection and dissemination of these two multi-resistant MRSA clones in Greece. The ClaI-Tn554 type of these clones (named KK) represents strains with one hybridization band with the transposon. 1 This fact can be explained by the loss of a large part of a previously integrated whole Tn554, carrying erm(A), and the acquisition of erm(C) by these strains, as a result of antibiotic selective pressure.
To our knowledge, this is the first surveillance study in Greece for erythromycin resistance in S. aureus. The overall erythromycin resistance rate was lower compared with those in other countries, 9,10 possibly due to the low use of MLS antibiotics in the hospitals. Erythromycin resistance was higher among MRSA (42% with MIC ≥ 4 mg/L) compared with MSSA (5%), with moderate variation during the 3 year period. Multicentre studies have already shown that resistance to macrolides is higher among MRSA, reaching 82%. 9, 10 (60) 35 ( Even though the predominance of erm(C) as the genetic determinant for the expression of resistance to MLS antibiotics among the total S. aureus population has been previously published, this is the first report of erm(C) predominance among MRSA, most likely due to the selection and dissemination of two major clones in the country. 
